Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01299259 · ClinicalTrials.gov registry record · NA

Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease

A NA study of Pelvic Inflammatory Disease, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
NA
Development phase
95
Enrollment target
1
Study location

NCT01299259 is a NA study of Pelvic Inflammatory Disease that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 95 participants, below the 151-participant average among 4 other Pelvic Inflammatory Disease trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01299259, a NA study of Pelvic Inflammatory Disease, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
NA
Development phase
95 participants
Enrollment target
1
Study location

Study Summary

The investigators hypothesize that text message reminders to girls diagnosed with pelvic inflammatory disease (PID) in the emergency department (ED) will improve follow-up to their primary care provider (PCP) after being discharged from the ED.

Interventions

  • BEHAVIORAL Text Message Reminders

Study Locations (1)

Pennsylvania

  • The Children's Hospital of Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2011-02
Est. Completion 2014-10
Phase NA

Sponsor

Children's Hospital of Philadelphia

431 total trials

What the Registry Record Tells You About NCT01299259

The ClinicalTrials.gov registry entry for NCT01299259 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 151-participant average among 4 other Pelvic Inflammatory Disease trials with a reported enrollment target (37% lower). The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pelvic Inflammatory Disease appearing as the primary indexed condition, and to 1 intervention - of which Text Message Reminders is the first listed.

NCT01299259 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01299259 about?

NCT01299259 is a clinical study titled "Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease". The investigators hypothesize that text message reminders to girls diagnosed with pelvic inflammatory disease (PID) in the emergency department (ED) will improve follow-up to their primary care provider (PCP) after being discharged from the ED.

What is the current status of trial NCT01299259?

This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2011-02. Estimated completion is 2014-10.

What conditions does trial NCT01299259 study?

This clinical trial studies the following conditions: Pelvic Inflammatory Disease.

What interventions are being tested in trial NCT01299259?

The interventions under investigation include: Text Message Reminders (BEHAVIORAL).

Who is sponsoring clinical trial NCT01299259?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01299259 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pelvic Inflammatory Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.